Yingying Xu

12PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersEpidemiological methodsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2025
Efficacy and safety of neoadjuvant ICI combined with chemotherapy in breast cancer from the perspective of a privileged population: a systematic review and meta-analysis.

Shiyang Liu, Xiang Li, Chen Wu

|Sep 04, 2023
Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors.

Xiuyun Chen, Mozhi Wang, Keda Yu

|Apr 13, 2023
Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study.

Litong Yao, Xiaoyan Liu, Mozhi Wang

|Mar 27, 2023
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity.

Yusong Wang, Mozhi Wang, Keda Yu

|Mar 07, 2023
Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation.

Hengjun Zhang, Mozhi Wang, Yingying Xu

|Jan 15, 2022
Targeting PGC1α to wrestle cancer: a compelling therapeutic opportunity.

Xiangyu Sun, Xiaoyan Liu, Keda Yu

Pageof 2

Frequent Collaborators

3 joint publications

Mozhi Wang

3 joint publications

Litong Yao

3 joint publications

Qiang Zhang

2 joint publications

Xinyan Li